Type 1 diabetes, hyperglycaemia, and the heart (Q37172723)

18 August 2017

1 reference

title

Type 1 diabetes, hyperglycaemia, and the heart (English)

1 reference

18 August 2017

0 references

1 reference

2

Bernard Zinman

1 reference

18 August 2017

Ravi Retnakaran

1

1 reference

PubMed ID

18502304

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

18 August 2017

1 reference

18 August 2017

371

1 reference

18 August 2017

9626

1 reference

18 August 2017

1790-1799

1 reference

Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus

18 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on Cardiovascular Complications of Type 1 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Prognosis of diabetics with diabetes onset before the age of thirty-one. I. Survival, causes of death, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The Pittsburgh insulin-dependent diabetes mellitus (IDDM) morbidity and mortality study. Mortality results.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Type 1 diabetes and coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

High risk of cardiovascular disease in patients with type 1 diabetes in the U.K.: a cohort study using the general practice research database

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Carotid artery intima-media thickness in children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Carotid intima-media thickness in pediatric type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Determinants of arterial nitrate-mediated dilatation in children: role of oxidized low-density lipoprotein, endothelial function, and carotid intima-media thickness.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Severity of coronary artery disease in young patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Biochemistry and molecular cell biology of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Progression of coronary artery calcium in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Diabetic autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Circadian blood pressure during the early course of type 1 diabetes. Analysis of 1,011 ambulatory blood pressure recordings in 354 adolescents and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Diabetic cardiomyopathy: a metabolic perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Diabetic cardiomyopathy: the search for a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The relationship of cardiac diastolic dysfunction to concurrent hormonal and metabolic status in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Diabetic cardiomyopathy revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Flow mediated dilatation and cardiac function in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Endothelium-dependent and -independent vascular dysfunction in type 1 diabetes: role of conventional risk factors, sex, and glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Mean HbA1c over 18 years predicts carotid intima media thickness in women with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Relation of hemoglobin A1c to left ventricular relaxation in patients with type 1 diabetes mellitus and without overt heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Improved glycemic control induces regression of left ventricular mass in patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Left ventricular mass reduction in type 1 diabetic patients with nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Association between glycosylated hemoglobin level and cardiovascular and all-cause mortality in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Nephropathy, but not retinopathy, is associated with the development of heart disease in Type 1 diabetes: a 12-year observation study of 462 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Editorial: Mortality and renal disease in type 1 diabetes mellitus--progress made, more to be done

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Coronary artery disease in IDDM. Gender differences in risk factors but not risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Apolipoprotein B independently predicts progression of very-low-level albuminuria in insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

High prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Early impairment of large artery structure and function in type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Cardiovascular disease in insulin dependent diabetes mellitus: similar rates but different risk factors in the US compared with Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Serum lipoproteins in the diabetes control and complications trial/epidemiology of diabetes intervention and complications cohort: associations with gender and glycemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

HDL composition predicts new-onset cardiovascular disease in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Epidemiological evidence for "double diabetes"

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Relationship between plasma sialic acid and fibrinogen concentration and incident micro- and macrovascular complications in type 1 diabetes. The EURODIAB Prospective Complications Study (PCS)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Soluble interleukin-2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Markers of endothelial dysfunction in the prediction of coronary artery disease in type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Serum cystatin C predicts progression of subclinical coronary atherosclerosis in individuals with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Familial Clustering of Cardiovascular Disease in Patients with Insulin-Dependent Diabetes and Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The association between a family history of type 2 diabetes and coronary artery disease in a type 1 diabetes population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The Functional -374 T/A RAGE Gene Polymorphism Is Associated With Proteinuria and Cardiovascular Disease in Type 1 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The apolipoprotein A-IV Gln360His polymorphism predicts progression of coronary artery calcification in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

A common promoter polymorphism in the hepatic lipase gene (LIPC-480C>T) is associated with an increase in coronary calcification in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Polymorphisms of the renin-angiotensin system genes predict progression of subclinical coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

C-reactive protein in type 1 diabetes and its relationship to coronary artery calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Low plasma adiponectin levels predict progression of coronary artery calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

Screening for coronary artery disease in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2960767-9

7 January 2021

10.1016/S0140-6736(08)60767-9

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18502304